Chronic exposure to low doses of pharmaceuticals disturbs the hepatic expression of circadian genes in lean and obese mice
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 276 (1) , 63-72
Abstract
No abstract availableKeywords
Funding Information
- Agence Nationale de la Recherche (ANR) (PHARMECO 09-CESA-014-01)
This publication has 41 references indexed in Scilit:
- Hepatocyte–Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular CarcinomaCancer Research, 2012
- Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie dietInternational Journal of Experimental Pathology, 2011
- Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesisBritish Journal of Pharmacology, 2011
- Hepatic Gene Expression Profiling Reveals Key Pathways Involved in Leptin-Mediated Weight Loss in ob/ob MicePLOS ONE, 2010
- Chronic Pain, Overweight, and Obesity: Findings from a Community-Based Twin RegistryThe Journal of Pain, 2010
- Circadian Rhythms and Metabolic SyndromeCirculation Research, 2010
- Synergistic Disruption of External Male Sex Organ Development by a Mixture of Four AntiandrogensEnvironmental Health Perspectives, 2009
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysisBMC Public Health, 2009
- Physiological significance of a peripheral tissue circadian clockProceedings of the National Academy of Sciences, 2008
- Low-Level Exposure to Multiple Chemicals: Reason for Human Health Concerns?Environmental Health Perspectives, 2007